A single-dose breast cancer drug to kill tumours with zero side effects
Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...
Labroots2d
FDA approval of new drug for hormone positive breast cancer
On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...
Single dose of novel drug shows tumor-clearing potential in breast cancer models
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women.
BioWorld2d
FDA approves Daiichi Sankyo’s Trop-2 ADC for breast cancer
Marking the second global approval after Japan, the U.S. FDA has approved Datroway (datopotamab deruxtecan), a trophoblast cell surface antigen 2-directed antibody-drug conjugate (ADC) from Daiichi ...
I'm A Breast Cancer Doctor. Here's What I Didn't Know — Until I Was Diagnosed Myself.
Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...
Medical Xpress9d
Discovery of estrogen receptor 'switches' may aid breast cancer treatment
Researchers at Case Western Reserve University School of Medicine have discovered how specific protein regions contribute to breast cancer ... on what is known as the estrogen receptor, a protein ...
HealthDay on MSN1d
Hormone Therapy Doesn't Increase Women's Risk of Brain Tumors
TUESDAY, Jan. 21, 2025 (HealthDay News) -- Hormone replacement therapy to ease menopause symptoms doesn’t increase a woman’s ...
FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer
The U.S. Food and Drug Administration approved AstraZeneca (AZN, AZN.L) and Daiichi Sankyo's (DSKYF.PK) Datroway (datopotamab ...